Crestline Management, LP Amicus Therapeutics, Inc. Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $1.7 Million - $2.11 Million	-123,222 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $880,416 - $1.14 Million	70,377 Added 133.18%	123,222 $1.77 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $620,400 - $833,894	52,845	52,845 $797,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.